NCT02488837

Brief Summary

The purpose of the study is to determine if non-invasive measurements of brain waves from the skin called electroencephalography (EEG) can predict whether the brain stimulator will help your symptoms. Our goal is to obtain these brain wave measurements with patients both awake and under general anesthesia, and then to evaluate which brain wave patterns are associated with clinical improvement to determine if they could be useful for predicting whether the surgery will work. If such predictive measures were established based upon the findings of this study, they could be used in the future to improve surgical outcomes in the following ways: (1) to help guide surgical targeting in the operating room awake or under anesthesia, (2) to guide post-operative programming in clinic, and (3) and to develop potential feedback systems for "automatic" programming of the brain stimulator system at home.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 29, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 2, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

May 11, 2018

Status Verified

May 1, 2018

Enrollment Period

2.5 years

First QC Date

June 29, 2015

Last Update Submit

May 9, 2018

Conditions

Keywords

Deep Brain Stimulation

Outcome Measures

Primary Outcomes (6)

  • Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

    Validated rating scale for measuring symptoms of Parkinson's disease

    Change in the rating scale score at 6 months post-op versus pre-op baseline

  • The Essential Tremor Rating Assessment Scale (TETRAS)

    Validated rating scale for measuring symptoms of essential tremor

    Change in the rating scale score at 6 months post-op versus pre-op baseline

  • Burke-Fahn-Marsden (BFM) Dystonia Rating Scale

    Validated rating scale for measuring symptoms of primary dystonia

    Change in the rating scale score at 6 months post-op versus pre-op baseline

  • Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)

    Validated rating scale for measuring symptoms of primary cervical/segmental dystonia

    Change in the rating scale score at 6 months post-op versus pre-op baseline

  • Yale Global Tic Severity Scale

    Validated rating scale for tic severity

    Change in the rating scale score at 6 months post-op versus pre-op baseline

  • Deep Brain Stimulation (DBS) Therapeutic Window

    Measurement of the available range of stimulation intensities for therapy for each contact on the DBS electrode array

    1 month post-operative scores for each contact on the DBS electrode array

Study Arms (1)

DBS subjects

deep brain stimulation (DBS) in patients with Parkinson's disease, tremor, dystonia, and Tourette's syndrome

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who undergo deep brain stimulation as part of routine clinical care for movement disorders (Parkinson's disease, essential tremor, dystonia, Tourette's syndrome).

You may qualify if:

  • Patients who elect to undergo deep brain stimulation as part of routine clinical care for movement disorders (Parkinson's disease, essential tremor, dystonia, Tourette's syndrome).
  • Adults, ages 19 and older

You may not qualify if:

  • Patients who are unable to consent to the research for cognitive or behavioral reasons
  • Patients who are medically too ill to participate, and
  • Patients who have their DBS programming at outside facilities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

Movement Disorders

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System Diseases

Study Officials

  • Harrison Walker, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Neurology

Study Record Dates

First Submitted

June 29, 2015

First Posted

July 2, 2015

Study Start

June 1, 2014

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

May 11, 2018

Record last verified: 2018-05

Locations